Infectious Diseases in Critical Care Medicine

101. Lehn N, Schaller E, Wagner H, et al. Frequency of toxic shock syndrome toxin- and enterotoxin-
     producing clinical isolates ofStaphylococcus aureus. Eur J Clin Microbiol Infect Dis 1995; 14(1):43–46.


102. Barrett JA, Graham DR. Toxic shock syndrome presenting as encephalopathy. J Infect 1986; 12(3):
     276–278.


103. Chesney RW, Chesney PJ, Davis JP, et al. Renal manifestations of the staphylococcal toxic-shock
     syndrome. Am J Med 1981; 71(4):583–588.


104. Herzer CM. Toxic shock syndrome: broadening the differential diagnosis. J Am Board Fam Pract
     2001; 14(2):131–136.


105. McKenna UG, Meadows JA III, Brewer NS, et al. Toxic shock syndrome, a newly recognized disease
     entity. Report of 11 cases. Mayo Clin Proc 1980; 55(11):663–672.


106. Chesney PJ, Davis JP, Purdy WK, et al. Clinical manifestations of toxic shock syndrome. JAMA 1981;
     246(7):741–748.


107. Andrews MM, Parent EM, Barry M, et al. Recurrent nonmenstrual toxic shock syndrome: clinical
     manifestations, diagnosis, and treatment. Clin Infect Dis 2001; 32(10):1470–1479.


108. Reingold AL, Dan BB, Shands KN, et al. Toxic-shock syndrome not associated with menstruation. A
     review of 54 cases. Lancet 1982; 1(8262):1–4.


109. Reingold AL, Hargrett NT, Dan BB, et al. Nonmenstrual toxic shock syndrome: a review of 130 cases.
     Ann Int Med 1982; 96(6 pt 2):871–874.


110. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The
     Working Group on Severe Streptococcal Infections. JAMA 1993; 269(3):390–391.


111. Manders SM. Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol 1998;
     39(3):383–398.


112. Ladhani S. Recent developments in staphylococcal scalded skin syndrome. Clin Microbiol Infect
     2001; 7(6):301–307.


113. Adesiyun AA, Lenz W, Schaal KP. Exfoliative toxin production byStaphylococcus aureusstrains
     isolated from animals and human beings in Nigeria. Microbiologica 1991; 14(4):357–362.


114. Dancer SJ, Noble WC. Nasal, axillary, and perineal carriage ofStaphylococcus aureusamong women:
     identification of strains producing epidermolytic toxin. J Clin Pathol 1991; 44(8):681–684.


115. Ladhani S, Poston SM, Joannou CL, et al. Staphylococcal scalded skin syndrome: exfoliative toxin A
     (ETA) induces serine protease activity when combined with A431 cells. Acta Paediatr 1999; 88(7):
     776–779.


116. Papageorgiou AC, Plano LR, Collins CM, et al. Structural similarities and differences in
     Staphylococcus aureusexfoliative toxins A and B as revealed by their crystal structures. Protein Sci
     2000; 9(3):610–618.


117. Prevost G, Couppie P, Monteil H. Staphylococcal epidermolysins. Curr Opin Infect Dis 2003; 16(2):
     71–76.


118. Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol 1979;
     100(1):69–86.


119. Melish ME. Staphylococci, streptococci and the skin: review of impetigo and staphylococcal scalded
     skin syndrome. Semin Dermatol 1982; 1:101–109.


120. Beers B, Wilson B. Adult staphylococcal scalded skin syndrome. Int J Dermatol 1990; 29(6):428–429.


121. Moss C, Gupta E. The Nikolsky sign in staphylococcal scalded skin syndrome. Arch Dis Child 1998;
     79(3):290.


122. Gemmell CG. Staphylococcal scalded skin syndrome. J Med Microbiol 1995; 43(5):318–327.


123. Cribier B, Piemont Y, Grosshans E. Staphylococcal scalded skin syndrome in adults. A clinical
     review illustrated with a new case. J Am Acad Dermatol 1994; 30(2 pt 2):319–324.


124. Goldberg NS, Ahmed T, Robinson B, et al. Staphylococcal scalded skin syndrome mimicking acute
     graft-vs.-host disease in a bone marrow transplant recipient. Arch Dermatol 1989; 125(1):85–87.


125. Ladhani S, Robbie S, Garratt RC, et al. Development and evaluation of detection systems for
     staphylococcal exfoliative toxin A responsible for scalded-skin syndrome. J Clin Microbiol 2001;
     39(6):2050–2054.


126. Gentilhomme E, Faure M, Piemont Y, et al. Action of staphylococcal exfoliative toxins on epidermal
     cell cultures and organotypic skin. J Dermatol 1990; 17(9):526–532.


127. Leyden JJ, Gately LE III. Staphylococcal and streptococcal infections. In: Sanders CV, Nesbitt LTJ,
     eds. The Skin and Infection: A color Atlas and Text. Baltimore: Williams and Wilkins, 1995:27–38.


128. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific
     desquamation of the fingers and toes in children. Arerugi 1967; 16(3):178–222.


129. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364(9433):533–544.


130. Royle J, Burgner D, Curtis N. The diagnosis and management of Kawasaki disease. J Paediatr Child
     Health 2005; 41(3):87–93.

Fever and Rash in Critical Care 45